Colorectal cancer in Crohn's disease - Review of a 56-year experience in Karolinska Institute University Hospital

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 4, 2008, Pages 257-266

  Rubio, Carlos A ^a   Befrits, Ragnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Crohn's colitis; Frequency

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

EID: 54549091131     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i4.20     Document Type: Review

References (114)

1. Goldgraber M, Kirsner J. Carcinoma of the colon in ulcerative colitis. Cancer. 1964;17:657-67.
2. Devroede G, Taylor W, Sauer W, Jackman RJ, Stickler GB. Cancer risk and the life expectancy of children with ulcerative colitis. N Engl J Med. 1971;285:17-29.
3. Counsell P, Dukes C. The association of chronic ulcerative colitis and carcinoma of the rectum and colon. Br J Surg. 1952;39:485-92.
4. Dawson I, Pryse-Davies J. The development of carcinoma of the large intetine in ulcerative colitis. Br J Surg. 1959;47:113-26.
5. Cook M, Goligher J. Carcinoma and epithelial dysplasia complicating ulcerative colitis. Gastroenterology. 1975;68:1127-35.
6. Lockhart-Mummery HE, Morson BC. Crohn's disease of the large intestine and its distinction from ulcerative colitis. Gut. 1960;1:87-105.
7. Weedon DD, Shorter RG, Ilstrup D, Huienza KA, Taylor W. Crohn's disease and cancer. New Engl J Med. 1973;289:1099-103.
8. Butt JH, Lennard-Jones JE, Ritchie JK. A practical approach to the risk of inflammatory bowel disease. Med Clin North Am. 1980;64:1203-19.
9. Andrews JM, Norton I, Owen D, Goulston K. Inflammatory bowel disease: a retrospective review of a specialist-based cohort. Med J Austr. 1995;163:133-6.
10. Fireman Z, Grossman P, Lilos P. Intestinal cancer in patients with Crohn's disease. A population-study in central Israel. Scand J Gastroenterol. 1989;24:346-50.
11. O'Keefe EA, Wright JP, Froggatt J, Zabow D. Medium-term follow-up of Crohn's disease in Cape Town (Review). South African Med J. 1989;76:139-41.
12. Lumley JW, Stitz RW. Crohn's disease and anal carcinoma. Aus N Z J Surg. 1991;61:46-7.
13. Persson PG, Karlen P, Bernell O. Crohn's disease and cancer: a population-based cohort study. Gastroenterology. 1994;107:1675-9.
14. Århen C. Risk of malignancy in Crohn's disease. Ital J Gastroenterol. 1979;11:131-8.
15. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology. 1993;105:1716-23.
16. Weterman IT, Biemond I, Pena AS. Mortality and cause of death in Crohn's disease. Review of 50 years'experience in Leiden University Hospital. Gut. 1990;31:1387-90.
17. Hellers G. Crohn's disease in Stockholm County 1955-1974. A study of epidemiology, results of surgical treatment, and long-term prognosis. Acta Chir Scand Suppl. 1979;490:1-84.
18. Connell WR, Sheffield JP, Kamm MA, Ritchie JK, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn's disease. Gut. 1994;35:347-52.
19. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990;336:357-19.
20. Rubio CA, Befrits R. Colorectal adenocarcinoma in Crohn's disease. a retrospective histologic study. Dis Colon Rectum. 1997;40:1072-8.
21. Eaden J. Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20:24-30.
22. Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-9.
23. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23:1097-104.
24. Friedman S. Cancer in Crohn's disease. Gastroenterol Clin North Am. 2006;35:621-39.
25. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum. 2007;50:839-55.
26. Lennard-Jones J E, Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2-6.
27. Rubio CA, Nesi G, Messerini L, Zampi GC, Mandai K, Itabashi M, Takubo K. The Vienna classification applied to colorectal adenomas. J Gastroenterol Hepatol. 2006;21:1697-703.
28. Rubio CA. Ectopic colonic mucosa in ulcerative colitis and in Crohn's disease of the colon. Dis Colon Rectum. 1984;27:182-6.
29. Rubio CA, Befritz R, Poppen B, Svenberg T, Slezak P. Crohn's disease and adenocarcinoma of the intestinal tract: report of four cases. Dis.Colon Rectum 1991;34:174-80.
30. Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut. 1997;41:480-6.
31. Lapidus A. The changing epidemiology of inflammatory bowel diseases. Acta Gastroenterol Belg. 2001;64:155-9.
32. Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481-9.
33. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Norregaard P, Moesgaard F, Bendtsen F, Munkholm P; the DCCD study group. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274-82.
34. Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol. 2001;13:1439-47.
35. Rubio CA, Befrits R, Ljung T, Jaramillo E, Slezak P. Colorectal carcinoma in ulcerative colitis is decreasing in Scandinavian countries. Anticancer Res. 2001;21:2921-4.
36. Herszenyi L, Miheller P, Tulassay Z Carcinogenesis in inflammatory bowel disease. Dig Dis. 2007;25:267-9.
37. Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335-42.
38. Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, Fléjou JF. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50:574-83.
39. Rodriguez-Bigas MA, Mahoney MC, Weber TK, Petrelli NJ. Colorectal cancer in patients aged 30 years or younger. Surg Oncol. 1996;5:189-94.
40. Itzkowitz SH. Inflammatory bowel disease and cancer. Gastroenterol Clin North Am. 1997;26:129-39.
41. Birkenmeier G, Goullon JE, Niedobitek F. Mucinous adenocarcinomas of the large intestine in Crohn disease Chirurg.1997;68:51-6.
42. Lumley JW, Hoffmann DC. Adenocarcinoma complicating an anorectal sinus in a patient with Crohn's disease. Aust N Z J Surg. 1997;67:66-7.
43. Marchetti F, Fazio VW, Ozuner G. Adenocarcinoma arising from a strictureplasty site in Crohn's disease. report of a case. Dis Colon Rectum. 1996 ;39:1315-21.
44. Dworak O, Hermanek P. Dysplasia-carcinoma sequence in chronic inflammatory bowel diseases Zentralbl Chir. 1998;123 Suppl:33-9.
45. Sperber K, Shim J, Mehra M, Lin A, George I, Ogata S, Mayer L, Itzkowitz S. Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues. Inflamm Bowel Dis. 1998;4:12-7.
46. Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, Pacini F, Masala G. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut. 1998;42:175-9.
47. Jain SK, Peppercorn MA. Inflammatory bowel disease and colon cancer: a review. Dig Dis. 1997;15:243-52.
48. Williams C. Is the incidence of cancer increased in patients with Crohn's disease or after its complications or treatment? Can J Gastroenterol. 1997;11:397-8.
49. Riegler G, Carratu R, Tartaglione M, Morace F, Manzione R, Arimoli A. Prevalence and relative risk of malignancy in relatives of inflammatory bowel disease patients and control subjects. J Clin Gastroenterol. 1998;27:211-4.
50. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum. 1998;41:992-6.
51. Korelitz BI. Carcinoma arising in Crohn's disease fistulae: another concern warranting another type of surveillance. Am J Gastroenterol. 1999;94:2337-9.
52. Ishibashi N, Hirota Y, Ikeda M, Hirohata T. Ulcerative colitis and colorectal cancer: a follow-up study in Fukuoka, Japan. Int J Epidemiol. 1999;28:609-13.
53. von Herbay A, Schmid RM, Adler G. Colorectal carcinomas in Crohn disease Dtsch Med Wochenschr. 1999;124:940-4.
54. Green S, Stock RG, Greenstein AJ. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:835-40.
55. Kulaylat MN, Gallina G, Bem J, Zeid M. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum.1999;42:826-8.
56. Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:459-77.
57. Sigel JE, Petras RE, Lashner BA, Fazio VW, Goldblum JR. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol. 1999;23:651-5.
58. Mayer R, Wong WD, Rothenberger DA, Goldberg SM, Madoff RD. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum. 1999;42:343-7.
59. Vernava AM 3rd. Cancer in chronic perianal fistulas of Crohn's disease. Dis Colon Rectum. 1999;42:282-3.
60. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer. 2000;83:89-90.
61. Koda K, Yoshino G, Honda S, Watanabe F, Sugimura H. Adenocarcinoma of the rectum with various grades of atypia in association with Crohn's disease: a case report and immunohistochemistry of p53 and Ki-67. Pathol Int. 2000;50:318-26.
62. Garcia Diaz E, Castro M, Romero Gomez M, Guerrero P, Romero A, Escribano L. Anal carcinoma in Crohn disease Gastroenterol Hepatol. 2000;23:150-1.
63. Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK, Olsen JH. Crohn's disease and cancer risk (Denmark). Cancer Causes Control. 2000;11:145-50.
64. Muller-Decker K, Albert C, Lukanov T, Winde G, Marks F, Furstenberger G. Cellular localization of cyclo-oxygenase isozymes in Crohn's disease and colorectal cancer. Int J Colorectal Dis. 1999;14:212-8.
65. Kirk GR, Clements WD. Crohn's disease and colorectal malignancy. Int J Clin Pract. 1999;53:314-5.
66. Freeman HJ. Colorectal cancer complicating Crohn's disease. Can J Gastroenterol. 2001;15:231-6.
67. Tiszlavicz L, Kapin M, Varkonyi A, Lorincz A, Bartyik K, Varkonyi T. Adenocarcinoma of the colon developing on the basis of Crohn's disease in childhood. Eur J Pediatr. 2001;160:168-72.
68. Koslowsky TC, Ganssauge C, Schlosser D, Siedek M. Two cases of colorectal cancer complicating Crohn's disease and review of the literature. Langenbecks Arch Surg. 2000;385:485-7.
69. Bernstein CN. Cancer surveillance in inflammatory bowel disease. Curr Gastroenterol Rep. 1999;1:496-504.
70. Wong NA, Shirazi T, Hamer-Hodges DW, Corfield AP, Lessells AM. Adenocarcinoma arising within a Crohn's-related anorectal fistula: a form of anal gland carcinoma? Histopathology. 2002;40:302-4.
71. Prati M, Quadri F, Botti F, Carrara A, De Simone M, Cioffi U, Contessini Avesani E. Intestinal carcinoma in Crohn's disease. Report of four cases and review of the literature. Minerva Chir. 2002;57:29-33.
72. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB. Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol. 2002;236:48-53.
73. Winkler R, Wittmer A, Heusermann U. Cancer and Crohn's disease. Z Gastroenterol. 2002;40:569-76.
74. Botterill ID, Sagar PM. Adenocarcinoma in the residual outflow tract after incomplete excision of a failed ileoanal pouch: a late complication of unrecognized Crohn's colitis: report of a case. Dis Colon Rectum. 2002;45:1112-5.
75. Ullman TA. Dysplasia and colorectal cancer in Crohn's disease. J Clin Gastroenterol. 2003;36 (Suppl):S75-8.
76. Sandmeier D, Bouzourene H. Adenocarcinoma in Crohn's disease. Histopathology. 2003;42:404-5.
77. Judge TA, Lewis JD, Lichtenstein GR. Colonic dysplasia and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002;12:495-523.
78. Lichtenstein GR. Reduction of colorectal cancer risk in patients with Crohn's disease. Rev Gastroenterol Disord. 2002;2 Suppl 2:S16-24.
79. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther. 2004;19:287-93.
80. Perea Garcia J, Zorrilla J, Lara VG, Munoz-Calero A. Colorectal adenocarcinoma in Crohn's disease. Med Clin 2003;121:757-8.
81. Rubio CA. Adenocarcinoma in inflammatory colorectal disease. histological features pertinent to local tumour progression. Anticancer Res. 2003;23:4313-8.
82. Sjodahl RI, Myrelid P, Soderholm JD. Anal and rectal cancer in Crohn's disease. Colorectal Dis. 2003;5:490-5.
83. Baisse B, Fontolliet C, Bian YS, Vuilleumier H, Benhattar J. Synchronous ileal and colonic adenocarcinomas associated with Crohn's disease: report of a case with a focus on genetic alterations and carcinogenesis. J Clin Pathol. 2004;57:885-7.
84. Tonelli F, Paroli GM. Colorectal Crohn's disease: indications to surgical treatment. Ann Ital Chir. 2003;74:665-72.
85. Krok KL, Lichtenstein GR. Colorectal cancer in infl ammatory bowel disease. Curr Opin Gastroenterol. 2004;20:43-8.
86. Nascimbeni R, Di Fabio F, Di Betta E, Mariani P, Fisogni S, Villanacci V. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol. 2005;18:681-5.
87. Mizushima T, Nezu R, Ito T, Uchikoshi F, Kai Y, Tamagawa H, Matsuda C, Yamagami Y, Inoue Y, Matsuda H. Three cases of colorectal cancer in patients with Crohn's disease. Nippon Shokakibyo Gakkai Zasshi. 2005;102:912-7.
88. Nicholson T, Orangio GR, Brandenburg D, Wolf DC, Pennington EE. Crohn's colitis presenting with node-negative colon cancer and liver metastasis after therapy with infliximab: report of two cases. Dis Colon Rectum. 2005;48:1651-5.
89. Laurent S, Barbeaux A, Detroz B, Detry O, Louis E, Belaiche J, Meurisse M. Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg. 2005;68:98-100.
90. Devroe H, Coene L, Mortelmans LJ, Jutten G. Colloid carcinoma arising in an anorectal fistula in Crohn's disease: a case report. Acta Chir Belg. 2005;105:110-1.
91. Ficari F, Fazi M, Garcea A, Nesi G, Tonelli F. Anal carcinoma occurring in Crohn's disease patients with chronic anal fistula. Suppl Tumori. 2005;4:S31.
92. Sjoqvist U, Befrits R, Soderlund S, Ost A, Karlen P, Tribukait B, Rubio CA, Rutgeerts P, Geboes K, Lofberg R. Colorectal cancer in colonic Crohn's disease - high frequency of DNA-aneuploidy. Anticancer Res. 2005;25:4393-7.
93. Kazama S, Hiramatsu T, Kobayashi R, Takabayashi N, Niwa H, Isono T, Suzuki H, Shimada S, Kimura M, Hara K, Kuriki K. Cancer in the anal canal, and in an anal fistula, that developed during a long-standing course of Crohn's disease. J Gastroenterol. 2005;40:1000-1.
94. Fox LP, Pasternack FR, Geyer AS, Grossman ME. Perineal squamous cell cancer in a patient with fistulizing and ulcerating Crohn's disease. Clin Exp Dermatol. 2005;30:718-9.
95. Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12:669-76.
96. Melichar B, Bures J, Dedic K. Anorectal carcinoma after infliximab therapy in Crohn's disease: report of a case. Dis Colon Rectum. 2006;49:1228-33.
97. Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis. 2006;12:491-6.
98. Palli D, Masala G, Sera F, Bagnoli S, d'Albasio G. Colorectal cancer risk in patients affected with Crohn's disease. Am J Gastroenterol. 2006;101:1400-1.
99. Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006;49:950-7.
100. Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology. 2006;130:1039-46.
101. Levi GS, Harpaz N. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease. Am J Surg Pathol. 2006;30:1022-9.
102. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, Ekbom A. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120:1356-62.
103. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91:854-62.
104. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med. 2000;67:227-40.
105. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 1996;91:44-8.
106. Yamazaki Y, Ribeiro MB, Sachar DB, Aufses AH Jr, Greenstein AJ. Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol. 1991;86:882-5.
107. Ribeiro MB, Greenstein AJ, Sachar DB, Barth J, Balasubramanian S, Harpaz N, Heimann TM, Aufses AH Jr. Colorectal adenocarcinoma in Crohn's disease. Ann Surg. 1996;223:186-93.
108. van Staa TP, Card T, Logan RF, Leufkens HG. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. 2005;54:1573-8.
109. Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 2003;125:1583-90.
110. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18 Suppl 2:1-5.
111. Moore-Maxwell CA, Robboy SJ. Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn's disease. Gynecol Oncol. 2004;93:266-8.
112. Zagoni T, Peter Z, Sipos F, Dichazi C, Tarjan Z, Dobo I, Kaszas I, Tulassay Z. Carcinoma arising in enterocutan fistulae of Crohn's disease patients: description of two cases. Int J Colorectal Dis. 2006;21:461-4.
113. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol. 1999;94:3248-53.
114. Sachar DB. Cancer in Crohn's disease: dispelling the myths. Gut. 1994;35:196-8.